Diamond Publications - Search Results

Search Again...

These results only include publications that have been reviewed and processed by Diamond Light Source. To also view papers that have not yet been processed click here.

You can use the folder icon under Actions to collate papers as required. You can then click on View Folder in the left-hand navigation to review and/or download your folder.

One item found (0 items not approved).

Instruments / Technical Area	Publication Details	Published	Actions
I02-Macromolecular Crystallography I03-Macromolecular Crystallography I04-Macromolecular Crystallography	Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials Tzu-Lan Yeh , Thomas m. Leissing , Martine I. Abboud , Cyrille C. Thinnes , Onur Atasoylu , James P. Holt-Martyn , Dong Zhang , Anthony Tumber , Kerstin Lippl , Christopher T. Lohans , Ivanhoe K. H. Leung , Helen Morcrette , Ian J. Clifton , Timothy D. W. Claridge , Akane Kawamura , Emily Flashman , Xin Lu , Peter J. Ratcliffe , Rasheduzzaman Chowdhury , Christopher W. Pugh , Christopher J. Schofield Chemical Science 30 DOI: 10.1039/C7SC02103H Diamond Proposal Number(s): [12346, 9306] Open Access Show Abstract ▼ Abstract: Inhibition of the human 2-oxoglutarate (2OG) dependent hypoxia inducible factor (HIF) prolyl hydroxylases (human PHD1–3) causes upregulation of HIF, thus promoting erythropoiesis and is therefore of therapeutic interest. We describe cellular, biophysical, and biochemical studies comparing four PHD inhibitors currently in clinical trials for anaemia treatment, that describe their mechanisms of action, potency against isolated enzymes and in cells, and selectivities versus representatives of other human 2OG oxygenase subfamilies. The ‘clinical’ PHD inhibitors are potent inhibitors of PHD catalyzed hydroxylation of the HIF-α oxygen dependent degradation domains (ODDs), and selective against most, but not all, representatives of other human 2OG dependent dioxygenase subfamilies. Crystallographic and NMR studies provide insights into the different active site binding modes of the inhibitors. Cell-based results reveal the inhibitors have similar effects on the upregulation of HIF target genes, but differ in the kinetics of their effects and in extent of inhibition of hydroxylation of the N- and C-terminal ODDs; the latter differences correlate with the biophysical observations.	Sep 2017

Instruments / Technical Area

Publication Details

Published

Actions

I02-Macromolecular Crystallography
I03-Macromolecular Crystallography
I04-Macromolecular Crystallography

Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials